Journal of Analytical Toxicology · 1990 · 41 citations · 0 references
PharmacyPharmacologyToxicologyDrug MetabolismForensic ToxicologyNeuropharmacologyMonoamine NeurochemistryPostmortem Drug AnalysisPostmortem ToxicologyStimulant PharmacologyStimulant ToxicologyAmphetamine DerivativesAmphetamine ToxicityForensic Stimulant ToxicologyMethamphetamine ToxicityPolypharmacy-related Toxicity
Selegiline is a relatively new antiparkinson's drug whose metabolites include methamphetamine and amphetamine. A 72-year-old female with apparently suicidal intentions was found dead at her residence. The cause of death was listed as coronary heart disease with a history of polypharmacy. The tissue methamphetamine and amphetamine concentrations resulting from selegiline administration are presented in this report.